US Patent

US11197830 — Pharmaceutical composition containing acetaminophen and ibuprofen

Method of Use · Assigned to AFT Pharmaceuticals Ltd · Expires 2039-02-27 · 13y remaining

Vulnerability score 70/100 Vulnerable — likely target for IPR or design-around

What this patent protects

This patent protects a pharmaceutical composition containing acetaminophen and ibuprofen in specific solid oral dosage forms.

USPTO Abstract

Solid oral dosage forms containing 325 mg of acetaminophen and 97.5 mg of ibuprofen or 500 mg of acetaminophen and 150 mg of ibuprofen, wherein the ibuprofen has a [D50] between 1 and 9 Î¼m, are described.

Drugs covered by this patent

chembl-chembl112 (ACETAMINOPHEN)

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-3553`	—	chembl-chembl112

Patent Metadata

Patent number: US11197830
Jurisdiction: US
Classification: Method of Use
Expires: 2039-02-27
Drug substance claim: No
Drug product claim: Yes
Assignee: AFT Pharmaceuticals Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.